Consolidated Overview of Notifiable Adverse Events in the U.S. President's Emergency Plan for AIDS Relief's Voluntary Medical Male Circumcision Program Through 2020.

Publication Year: 2022

DOI:
10.1007/s11904-022-00636-8

PMCID:
PMC9643893

PMID:
36348185

Journal Information

Full Title: Curr HIV/AIDS Rep

Abbreviation: Curr HIV/AIDS Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of InterestThe authors declare no competing interests. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. DisclaimerThis publication has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. Conflict of Interest The authors declare no competing interests."

Evidence found in paper:

"Declarations: Conflict of InterestThe authors declare no competing interests.: Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors.: DisclaimerThis publication has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. Disclaimer: This publication has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025